ArticlePreventive medicine reports2026
Geographic Analysis of Access to the National Diabetes Prevention Program in New York State.
Article in Preventive medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Prediabetes affects 1.7 million adults in New York State (NYS), with higher rates among racial/ethnic minoritized and low socioeconomic status populations. This study examined access to the National Diabetes Prevention Program (DPP) - an evidence-based program to prevent/delay diabetes onset - among NYS residents with prediabetes. Methods: Self-reported prediabetes diagnosis, zip code, and sociodemographic characteristics were obtained from a sample of 39,095 adults from the 2021 NYS Behavioral Risk Factor Surveillance System. National DPP site location and recognition status were obtained from the CDC Diabetes Prevention Recognition Program Registry. Geospatial analysis defined 30-min drive-time buffers around National DPP sites. The proportion of NYS residents with prediabetes living within a 30-min drive of a site was computed. Results: Prediabetes prevalence ranged from 5.6%-18.5% across counties; ten counties had rates >15%. There were 117 National DPP sites in NYS. The majority of residents (84.3%) with prediabetes lived within a 30-min drive of a site. Access varied by race and ethnicity, with greater access among Black, Asian, and Hispanic than among White respondents. Conclusions: Although most NYS residents with prediabetes have access to the National DPP, areas of unavailability remain. Expansion efforts should focus on counties with high prediabetes rates and limited program availability.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.